Abstract
Aluminum has been shown in a number of studies to cause intoxication and cell death in a variety of animal species. There is also considerable evidence that aluminum plays some role in the pathogenesis of Alzheimer’s disease and in encephalopathy suffered by patients undergoing hemodialysis. Fatal dialysis encephalopathy in patients undergoing haemodialysis was first described in 1972 by Alfrey et al. and was subsequently shown to be caused by the accumulation of aluminum in the grey matter (Alfrey et al., 1976). The aluminum is derived from aluminum containing antacids and from the dialysate itself.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alfrey, A.C., Mishell, J.M., and Burks, J., 1972, Syndrome of dyspraxia and multifocal seizures associated with chronic hemodialysis, Trans. Am. Soc. Artif. Intern. Organs, 18: 257–260.
Alfrey, A.C., LeGendre, G.R., and Kaehny, W.D., 1976, The dialysis encephalopathy syndrome: possible aluminum intoxication, New Engl. J. Med., 294: 184–188.
Banks, W.A., and Kastin, A.J., 1983, Aluminum increases permeability of the blood-brain barrier to labelled DSIP and β-endorphin: possible implications for senile and dialysis dementia, Lancet, 2: 1227–1229.
Knox, W.E., and Mehler, A.H., 1951, The adaptive increase of the tryptophan peroxidase-oxidase system of the liver, Science, 113: 237–238.
Lai, J.C.K., and Blass, J.P., 1984, Inhibition of brain glycolysis by aluminum, J. Neurochem., 42: 438–446.
Leeming, R.J., and Blair, J.A., 1979, Dialysis dementia, aluminum, and tetrahydrobiopterin metabolism, Lancet, 1: 556.
McLachan, C., Dam T-V., Farnell, B.J., and Lewis P.N., 1983, Aluminum inhibition of ADP-ribosylation in vivo and in vitro. Neurobehav. Toxicol. Teratol., 15: 645–650.
Moroni, F., Lombardi, G., Carlà, V., and Moneti, G., 1984, The excitotoxin quinolinic acid is present and unevenly distributed in the rat brain, Brain Res., 295: 352–355.
Perkins, M.N., and Stone, T.W., 1982, An iontophoretic investigation of the actions of convulsant kynurenines and their interactions with the endogenous excitant quinolinic acid, Brain Res., 247: 184–187.
Schwarcz, R., Whetsell, W.O., and Mangano, R.M., 1983, Quinolinic acid: an endogenous metabolite that produces axon sparing lesions in rat brain, Science, 219: 316–318.
Sharp, T.R., and Rosenberry, T.L., 1985, Ionic strength dependence of acetlycholinesterase activity of Al3+, Biophys. Chem., 21: 261.
Tsuzuki, Y., and Marquis, J.K., 1985, Investigations of the interaction of aluminum with bovine plasma monoamine oxidase, Bull. Environ. Contain. Toxicol., 34: 451–455.
Yates, C.M., Simpson, J., Russell, D., and Gordon, A., 1980, Cholinergic enzymes in neurofibrillary degeneration produced by aluminum, Brain Res., 197: 269–274.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Plenum Press, New York
About this chapter
Cite this chapter
Connick, J.H., Lombardi, G., Moroni, F., Hall, E., Taylor, A., Stone, T.W. (1991). The Effect of Aluminum on Rat Brain and Liver Quinolinic Acid Concentrations. In: Schwarcz, R., Young, S.N., Brown, R.R. (eds) Kynurenine and Serotonin Pathways. Advances in Experimental Medicine and Biology, vol 294. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5952-4_44
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5952-4_44
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5954-8
Online ISBN: 978-1-4684-5952-4
eBook Packages: Springer Book Archive